Menu
Not yet recruiting NCT06963762

The Effect of Mirror Therapy Applied to Stroke Patients on Motor-Sensory Status and Quality of Life

No phase Interventional Stroke Mirror Movement Therapy Rehabilitation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Conventional rehabilitation will be applied, Mirror therapy will be applied along with conventional rehabilitation.
Who it may be relevant to
Registry conditions: Stroke, Mirror Movement Therapy, Rehabilitation. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Purpose: The research will be conducted to evaluate the effect of Mirror Therapy applied to Stroke Patients on motor-sensory status and quality of life. Method: The research will be carried out as a randomized controlled experimental study at Bilecik Training and Research Hospital and Bozüyük State Hospital between 01.08.2024-01.05.2025. The population of the research consists of 350 people. Individuals will be distributed to the experimental (30) and control (30) groups by simple randomization method. In collecting research data; The patient introduction form, Brunnstrom Staging and SF-36 Quality of Life Scale will be administered to the patients in both groups by the researcher using face-to-face interview technique (pre-test). Patients in the experimental group will be informed about mirror therapy. In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks. Patients in the control group will only receive conventional rehabilitation for 30 minutes, 4 times a week for 4 weeks. At the end of the 4th week, patients in both groups will be administered Brunnstrom Staging and SF-36 Quality of Life Scale (posttest). If both groups are discharged before 4 weeks, the planned practices will continue at home.

Interventions

  • Behavioral Conventional rehabilitation will be applied
    Conventional rehabilitation will be applied for 30 minutes, 4 times a week for 4 weeks.
  • Behavioral Mirror therapy will be applied along with conventional rehabilitation
    In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.

Primary outcome measures

  • Brunnstrom Motor-Sensory Staging [Time frame: 1 month]
Secondary outcome measures (1)
  • SF-36 Quality of Life Scale [Time frame: 1 month]

Eligibility criteria

Inclusion criteria

  • Being literate,
  • Being over the age of 18,
  • Having sufficient communication skills to answer oral and written questions and follow instructions,
  • Having been diagnosed with a stroke and at least 6 days have passed since it occurred,
  • Not having severe vision problems,
  • Not having a vertigo problem,
  • Not having been diagnosed with epilepsy,
  • Upper extremity Stage 2 and above in Brunnstrom staging
  • Lower extremity Stage 2 and above in Brunnstrom staging

Exclusion criteria

  • Being under 18 years of age
  • Upper extremity Stage 2 and below in Brunnstrom staging
  • In Brunnstrom staging, Lower extremity Stage 2 and below

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Sequential
Masking
Open label
Primary purpose
Health services research

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06963762 · ATAÜNİ-SBE-AS-03

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗